318 related articles for article (PubMed ID: 25921475)
1. Medicaid coverage of medications to treat alcohol and opioid dependence.
Mark TL; Lubran R; McCance-Katz EF; Chalk M; Richardson J
J Subst Abuse Treat; 2015 Aug; 55():1-5. PubMed ID: 25921475
[TBL] [Abstract][Full Text] [Related]
2. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.
Mark TL; Kassed CA; Vandivort-Warren R; Levit KR; Kranzler HR
Drug Alcohol Depend; 2009 Jan; 99(1-3):345-9. PubMed ID: 18819759
[TBL] [Abstract][Full Text] [Related]
3. Addiction pharmacotherapy 2000: new options, new challenges.
Rawson RA; McCann MJ; Hasson AJ; Ling W
J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for Substance Use Disorders.
Klein JW
Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
[TBL] [Abstract][Full Text] [Related]
5. Decline in Buprenorphine/Naloxone Prescriptions in a State Medicaid Population Following Formulary Conversion from Suboxone to Bunavail.
Soper R; Appajosyula S; Deximo C
Adv Ther; 2018 Apr; 35(4):457-466. PubMed ID: 29623562
[TBL] [Abstract][Full Text] [Related]
6. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
[TBL] [Abstract][Full Text] [Related]
7. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.
Grogan CM; Andrews C; Abraham A; Humphreys K; Pollack HA; Smith BT; Friedmann PD
Health Aff (Millwood); 2016 Dec; 35(12):2289-2296. PubMed ID: 27920318
[TBL] [Abstract][Full Text] [Related]
8. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
[No Abstract] [Full Text] [Related]
9. Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.
Parrino MW; Maremmani AG; Samuels PN; Maremmani I
J Addict Dis; 2015; 34(2-3):255-62. PubMed ID: 26110357
[TBL] [Abstract][Full Text] [Related]
10. Availability of addiction medications in private health plans.
Horgan CM; Reif S; Hodgkin D; Garnick DW; Merrick EL
J Subst Abuse Treat; 2008 Mar; 34(2):147-56. PubMed ID: 17499959
[TBL] [Abstract][Full Text] [Related]
11. Coverage of Medications That Treat Opioid Use Disorder and Opioids for Pain Management in Marketplace Plans, 2017.
Huskamp HA; Riedel LE; Barry CL; Busch AB
Med Care; 2018 Jun; 56(6):505-509. PubMed ID: 29668645
[TBL] [Abstract][Full Text] [Related]
12. Cost and utilization outcomes of opioid-dependence treatments.
Baser O; Chalk M; Fiellin DA; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S235-48. PubMed ID: 21761950
[TBL] [Abstract][Full Text] [Related]
13. Methadone maintenance and state Medicaid managed care programs.
McCarty D; Frank RG; Denmead GC
Milbank Q; 1999; 77(3):341-62, 274. PubMed ID: 10526548
[TBL] [Abstract][Full Text] [Related]
14. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
Srivastava A; Kahan M; Nader M
Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
[TBL] [Abstract][Full Text] [Related]
15. How do state Medicaid programs determine what substance use disorder treatment medications need prior authorization? An overview for clinicians.
Bachhuber MA
Addict Sci Clin Pract; 2020 Jun; 15(1):20. PubMed ID: 32600402
[TBL] [Abstract][Full Text] [Related]
16. Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving.
Soyka M
Evid Based Ment Health; 2013 Aug; 16(3):71. PubMed ID: 23604277
[No Abstract] [Full Text] [Related]
17. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
18. Opioid antagonists for the treatment of alcohol dependence.
Yancey JR; Lumbad J
Am Fam Physician; 2011 Nov; 84(9):990-2. PubMed ID: 22046937
[No Abstract] [Full Text] [Related]
19. Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.
Mojtabai R; Mauro C; Wall MM; Barry CL; Olfson M
Health Aff (Millwood); 2019 Jan; 38(1):14-23. PubMed ID: 30615514
[TBL] [Abstract][Full Text] [Related]
20. International update: new findings on promising medications.
Litten RZ
Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):216A-218A. PubMed ID: 8947268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
